Similarly, compared with AAV-mHTT (103Q) + vehicle control HD mice, AAV-mHTT (103Q)-induced HD mice treated with genistein presented reduced MMP14 expression, diminished ECM degradation, and preserved MSN morphology (Supplementary Fig. 14). The gene discussed is MMP14; the disease is Huntington disease.